Guardant360
Commercial- Indications
- Solid tumors, Non-small cell lung cancer
Company intelligence / Profile preview
Guardant Health
Palo Alto, California, United Statesinvestors.guardanthealth.com ↗
- Ownership
- Public · GH
- Employees
- ~5000
- Development stage
- Commercial
01
Overview
Guardant Health has developed FDA-approved liquid biopsy tests for comprehensive genomic profiling in advanced cancer patients. Their Guardant360 CDx test is FDA-approved as a companion diagnostic for patients who may benefit from specific cancer treatments. Their colorectal cancer screening test showed 83% accuracy in detecting cancer with a 10% false positivity rate in a study of 20,000 participants[3][6].
- Therapeutic areas
- Oncology
- Modalities
- Liquid biopsy testsBlood-based cancer testsTissue tests
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Pfizer (announced April 24, 2025)[7]Meaningful Insights Biotech Analytics (MiBA) (announced December 20, 2024)[10]
04
Financials
- Market cap
- $21.8B
- Total revenue
- $335M
- Enterprise value
- $22.5B
Beyond the preview
Go deeper on Guardant Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guardant Health.